Publications by authors named "Radi Al Chalabi"
Article Synopsis
- Atopic Dermatitis (AD) affects 2-5% of adults, causing severe itching, sleep disturbances, and decreased quality of life, highlighting the need for effective treatments like Dupilumab.
- A new survey tool, called ADCT, was used to evaluate the self-reported efficacy of Dupilumab in Qatari patients, measuring six symptoms on a scale of 0 to 3 and assessing their impact on daily life after four weeks of treatment.
- Results showed a significant reduction in AD symptoms, with mean ADCT scores dropping from 17.6 at baseline to 4.1 at four weeks, indicating an impressive improvement in the patients' overall condition and itch severity.